These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8707460)

  • 41. Relationship between peripheral diabetic neuropathy and microvascular reactivity in patients with type 1 and type 2 diabetes mellitus -- neuropathy and microcirculation in diabetes.
    Kasalová Z; Prázný M; Skrha J
    Exp Clin Endocrinol Diabetes; 2006 Feb; 114(2):52-7. PubMed ID: 16570233
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimum maintenance trough levels of cyclosporine in heart transplant recipients given corticosteroid-free regimen.
    Nohria A; Ehtisham J; Ramahi TM
    J Heart Lung Transplant; 1998 Sep; 17(9):849-53. PubMed ID: 9773855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of HLA A, B, and DR blood transfusions and immune responder status on cardiac allograft recipients treated with cyclosporine.
    Kerman RH; van Buren CT; Lewis RM; Frazier OH; Cooley D; Kahan BD
    Transplantation; 1988 Feb; 45(2):333-7. PubMed ID: 3278425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term renal function in heart transplant recipients receiving cyclosporine therapy.
    Goral S; Ynares C; Shyr Y; Yeoh TK; Johnson HK
    J Heart Lung Transplant; 1997 Nov; 16(11):1106-12. PubMed ID: 9402509
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiovascular adaptation to cyclosporine-induced hypertension.
    Ventura HO; Lavie CJ; Messerli FH; Valentino V; Smart FW; Stapleton DD; Ochsner JL
    J Hum Hypertens; 1994 Apr; 8(4):233-7. PubMed ID: 8021902
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Skin microvascular reactivity in patients with hypothyroidism.
    Mihor A; Gergar M; Gaberšček S; Lenasi H
    Clin Hemorheol Microcirc; 2016 Nov; 64(1):105-114. PubMed ID: 27258198
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vascular reactivity in acromegalic patients: preliminary evidence for regional endothelial dysfunction and increased sympathetic vasoconstriction.
    Maison P; Démolis P; Young J; Schaison G; Giudicelli JF; Chanson P
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):445-51. PubMed ID: 11012569
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neither cyclosporine nor tacrolimus deteriorate endothelial function in renal transplant recipients assessed with reactive hyperernia index.
    Grabczewska Z; Obońska K; Adamowicz A; Kasprzak M; Włodarczyk Z; Kubica J
    Transplant Proc; 2013 May; 45(4):1567-70. PubMed ID: 23726621
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low incidence of neoplasia in heart and heart-lung transplant recipients receiving triple-drug immunosuppression.
    Olivari MT; Diekmann RA; Kubo SH; Braunlin E; Jamieson SW; Ring WS
    J Heart Transplant; 1990; 9(6):618-21. PubMed ID: 2277297
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Abnormal neuroendocrine responses during exercise in heart transplant recipients.
    Braith RW; Wood CE; Limacher MC; Pollock ML; Lowenthal DT; Phillips MI; Staples ED
    Circulation; 1992 Nov; 86(5):1453-63. PubMed ID: 1423959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of orthotopic cardiac transplantation on peripheral vascular function in congestive heart failure: influence of cyclosporine therapy.
    Cavero PG; Sudhir K; Galli F; DeMarco T; Keith F; Chatterjee K
    Am Heart J; 1994 Jun; 127(6):1581-7. PubMed ID: 8197986
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipoprotein(a) selectively impairs receptor-mediated endothelial vasodilator function of the human coronary circulation.
    Schachinger V; Halle M; Minners J; Berg A; Zeiher AM
    J Am Coll Cardiol; 1997 Oct; 30(4):927-34. PubMed ID: 9316520
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression.
    Goldstein DJ; Zuech N; Sehgal V; Weinberg AD; Drusin R; Cohen D
    Transplantation; 1997 Mar; 63(5):664-8. PubMed ID: 9075835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of laser speckle contrast imaging with laser Doppler for assessing microvascular function.
    Tew GA; Klonizakis M; Crank H; Briers JD; Hodges GJ
    Microvasc Res; 2011 Nov; 82(3):326-32. PubMed ID: 21803051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclosporine therapy after cardiac transplantation causes hypertension and renal vasoconstriction without sympathetic activation.
    Kaye D; Thompson J; Jennings G; Esler M
    Circulation; 1993 Sep; 88(3):1101-9. PubMed ID: 8394783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety and efficacy of pravastatin therapy for the prevention of hyperlipidemia in pediatric and adolescent cardiac transplant recipients.
    Penson MG; Fricker FJ; Thompson JR; Harker K; Williams BJ; Kahler DA; Schowengerdt KO
    J Heart Lung Transplant; 2001 Jun; 20(6):611-8. PubMed ID: 11404165
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Soluble interleukin-2-receptor levels as a marker of coronary microvascular dysfunction after heart transplantation.
    Weis M; Hartmann A; Scheuermann EH; Olbrich HG
    J Heart Lung Transplant; 1998 Mar; 17(3):294-8. PubMed ID: 9563606
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term results of triple-drug-based immunosuppression in nonneonatal pediatric heart transplant recipients.
    Gajarski RJ; Smith EO; Denfield SW; Rosenblatt HM; Kearney D; Frazier OH; Radovancevic B; Price JK; Kertesz NJ; Towbin JA
    Transplantation; 1998 Jun; 65(11):1470-6. PubMed ID: 9645805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation.
    Scherrer U; Vissing SF; Morgan BJ; Rollins JA; Tindall RS; Ring S; Hanson P; Mohanty PK; Victor RG
    N Engl J Med; 1990 Sep; 323(11):693-9. PubMed ID: 2388667
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peripheral microvascular dysfunction as an independent predictor of atherosclerotic damage in type 1 diabetes patients: a preliminary study.
    Rossi M; Matteucci E; Pesce M; Consani C; Franzoni F; Santoro G; Giampietro O
    Clin Hemorheol Microcirc; 2013; 54(4):381-91. PubMed ID: 23089884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.